Neurological Surgery Doctors in Farmington, CT Accepting Medicare

6 Neurological Surgery doctors found. Showing 1 - 6

Mr. Ian Thomas Mcneill, Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 263 Farmington Ave, Farmington, CT 06030 Phone: 860-679-8080    Fax: 860-679-1430

Mr. Brian Joseph Kelley, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 263 Farmington Ave, Farmington, CT 06030 Phone: 860-679-8080    Fax: 860-679-1430

Hilary C Onyiuke, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 263 Farmington Ave, Farmington, CT 06030 Phone: 860-679-4228    Fax: 860-679-1419

Michael Joseph Giordano, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 263 Farmington Ave, Farmington, CT 06030 Phone: 860-679-4228    Fax: 860-679-1419

David Choi, M.D. Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 263 Farmington Avenue, Farmington, CT 06030 Phone: 860-679-8080    Fax: 860-679-0131

Richard Simon, Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 263 Farmington Ave, Farmington, CT 06030 Phone: 860-679-4228

News Archive

Targeting TAAR5 can provide a new treatment opportunity for neurodegenerative disorders

St Petersburg University researchers, led by Professor Raul R. Gainetdinov, Director of the Institute of Translational Biomedicine and Academic Supervisor of the St Petersburg University Hospital, have found a new role for recently discovered neurotransmitter system that uses the trace amine-associated receptor 5 (TAAR5) for neurotransmission.

2 genes influence social behavior, visual-spatial performance in people with Williams syndrome

Unraveling the genetics of social behavior and cognitive abilities, researchers at the University of Utah and the Salk Institute for Biological Studies have traced the role of two genes,GTF2I and GTF2IRD, in a rare genetic disorder known as Williams Syndrome.

Clinical Genomics' blood test detects twice the number of colorectal cancer recurrence cases than CEA testing

Clinical Genomics, a private company developing innovative diagnostic tools for colorectal cancer, today announced that data supporting its two-gene circulating tumor DNA (ctDNA) blood test for post-surgical monitoring of colorectal cancer (CRC) recurrence have been published online by Cancer Medicine, and will appear in the October issue.

South Florida Sun-Sentinel profiles Florida's crisis pregnancy centers

The South Florida Sun-Sentinel on Monday profiled the Hope Crisis Pregnancy Centers in Florida.

Researchers have discovered a safe, non-invasive way to manage blood sugar

Researchers from the University of Iowa may have discovered a safe new way to manage blood sugar non-invasively. Exposing diabetic mice to a combination of static electric and magnetic fields for a few hours per day normalizes two major hallmarks of type 2 diabetes, according to new findings published Oct. 6 in Cell Metabolism.

Read more Medical News

› Verified 9 days ago